New treatment trial aims to give kids with kidney disease more time between Flare-Ups
NCT ID NCT07388810
Summary
This study is testing whether one dose or two doses of the medication ripertamab works better for children with a specific type of kidney disease that keeps coming back. The goal is to help children stay in remission longer and reduce their need for steroid medications, which can have significant side effects. Researchers will compare how long children stay flare-up free and how much steroid medicine they need over a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRNS/SDNS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province 310052
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.